The Directigen Meningitis Combo Test is a presumptive latex agglutination test for the direct qualitative detection of antigens to H. influenzae type b, S. pneumoniae, N. meningitidis groups A, B, C, Y or W135 and Escherichia coli K1 in cerebrospinal fluid (CSF), serum or urine
The test can also be used for the direct qualitative detection of antigens to group B Streptococcus in CSF and serum
In addition, the test kit provides confirmation and serogrouping capabilities from suspected colonies of H. influenzae type b, S. pneumoniae, group B Streptococcus, and N. meningitidis groups A / Y, B or C / W135
Visible agglutination occurs when a sample containing any of these bacterial antigens is reacted with its respective antibody-coated latex beads
One 9 mL bottle Positive Control , one 9 mL bottle Negative Control , one 1 mL bottle H. influenzae type b antibody, Reagent 1 , one 1 mL bottle S. pneumoniae antibody, Reagent 2 , one 1 mL bottle Group B Streptococcus antibody, Reagent 3
One 1 mL bottle N. meningitidis Groups C and W135 antibody, Reagent 4 , one 1 mL bottle N. meningitidis Groups A and Y antibody, Reagent 5 , one 1 mL bottle N. meningitidis Group B/ E. coli K1 antibody, Reagent 6
One 8 mL bottle Specimen B one 0.5 mL bottle control latex Reagent A (rabbit) , one 0.5 mL bottle control latex Reagent B (mouse) 30 single use test cards , plastic stirrers, workstation and procedure chart
90 determinations (30 patient tests, 60 controls)
Read the test results macroscopically under a high intensity incandescent light
90 determinations (30 patient tests, 60 controls)
WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov
McKesson #
174043
Manufacturer #
252360
Brand
Directigen Meningitis Combo
Manufacturer
BD
Country of Origin
United States
Application
Rapid Test Kit
CLIA Classification
CLIA Moderate Complexity for Direct AG, Visual / CLIA High Complexity for Blood Culture
Contents
(6) 1 mL Reagents 1 to 6, (2) 0.5 mL Reagent A and B, 9 mL Positive Control, 9 mL Negative Control, 8 mL Specimen Buffer
